| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/12/1999 | WO1999040222A1 Mismatch detection techniques |
| 08/12/1999 | WO1999040221A2 Method for quantitatively analyzing tumor cells in a body fluid and test kits suited therefor |
| 08/12/1999 | WO1999040220A2 Method of screening therapeutic agents |
| 08/12/1999 | WO1999040217A1 Process for processing sucrose into glucose and fructose |
| 08/12/1999 | WO1999040214A2 Nucleic acid delivery vehicles |
| 08/12/1999 | WO1999040213A1 Genetic manipulation of spermatogonia |
| 08/12/1999 | WO1999040212A2 Bacteriophage vectors generated by bacteriophage/plasmid recombination |
| 08/12/1999 | WO1999040211A2 Strawberry fruit promoters for gene expression |
| 08/12/1999 | WO1999040210A1 Suppression of alpha-amylase and protease expression using a serine/threonine protein kinase |
| 08/12/1999 | WO1999040209A1 Alteration of amino acid compositions in seeds |
| 08/12/1999 | WO1999040208A1 In vivo construction of dna libraries |
| 08/12/1999 | WO1999040207A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA |
| 08/12/1999 | WO1999040206A1 Plant alkaline and neutral invertases |
| 08/12/1999 | WO1999040205A1 Glycosyltransferase and dna encoding the same |
| 08/12/1999 | WO1999040204A1 Single-chain polypeptides comprising creatine kinase m and creatine kinase b |
| 08/12/1999 | WO1999040203A1 Yeast strains with interrupted atf2 gene and uses |
| 08/12/1999 | WO1999040201A1 Protein |
| 08/12/1999 | WO1999040200A1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE |
| 08/12/1999 | WO1999040199A2 A novel fungal protein critical for expression of fungal proteins |
| 08/12/1999 | WO1999040198A2 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 08/12/1999 | WO1999040197A2 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf |
| 08/12/1999 | WO1999040196A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 08/12/1999 | WO1999040195A1 Mammalian receptor proteins; related reagents and methods |
| 08/12/1999 | WO1999040194A1 Materials and methods for identifying and analyzing intermediate tandem repeat dna markers |
| 08/12/1999 | WO1999040193A1 Angiopoietin homolog zapo3, dna encoding it, and method of making it |
| 08/12/1999 | WO1999040192A1 Human receptor gpr14, and a method of finding agonist and antagonist to human and rat gpr14 |
| 08/12/1999 | WO1999040191A1 Dnas or genes participating in parkinson's disease |
| 08/12/1999 | WO1999040190A1 Human tsc403 gene and human ing1l gene |
| 08/12/1999 | WO1999040189A2 Cdnas encoding secreted proteins |
| 08/12/1999 | WO1999040188A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations |
| 08/12/1999 | WO1999040187A1 Nucleic acids provided for modulating cellular activation |
| 08/12/1999 | WO1999040186A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences |
| 08/12/1999 | WO1999040185A1 Cytotoxic heteromeric protein combinatorial libraries |
| 08/12/1999 | WO1999040184A1 Dendritic enriched secreted lymphocyte activation molecule |
| 08/12/1999 | WO1999040183A1 Human serine protease and serpin polypeptides |
| 08/12/1999 | WO1999040182A2 CRYSTALLINE TNF-α-CONVERTING ENZYME AND USES THEREOF |
| 08/12/1999 | WO1999040181A1 Growth differentiation factor-8 |
| 08/12/1999 | WO1999040179A1 Compositions and methods for controlling genetically engineered organisms |
| 08/12/1999 | WO1999040173A1 Substrates for immobilizing and amplifying dna, dna-immobilized chips having dna immobilized on the substrates, and method for amplifying dna |
| 08/12/1999 | WO1999040119A1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 08/12/1999 | WO1999040117A1 THREE-DIMENSIONAL STRUCTURES AND MODELS OF Fc RECEPTORS AND USES THEREOF |
| 08/12/1999 | WO1999040115A2 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT |
| 08/12/1999 | WO1999040114A1 Novel gabab receptor dna sequences |
| 08/12/1999 | WO1999040112A1 Neuroprotective peptides and uses thereof |
| 08/12/1999 | WO1999040111A1 The aiolos gene |
| 08/12/1999 | WO1999040110A1 Breast cancer resistance protein (bcrp) and the dna which encodes it |
| 08/12/1999 | WO1999040109A2 Recombinant mistletoe lectines |
| 08/12/1999 | WO1999040105A2 Array fabrication methods |
| 08/12/1999 | WO1999040104A1 Neokine protein and nucleic acid molecules and uses therefor |
| 08/12/1999 | WO1999040102A1 Novel molecules of the card-related protein family and uses thereof |
| 08/12/1999 | WO1999040100A1 45 human secreted proteins |
| 08/12/1999 | WO1999040098A1 Method for isolating and purifying nucleic acids |
| 08/12/1999 | WO1999040038A1 Substrate for array printing |
| 08/12/1999 | WO1999039817A1 Method of quality control in manufacturing processes |
| 08/12/1999 | WO1999039744A1 Compositions and methods for polynucleotide delivery |
| 08/12/1999 | WO1999039742A1 Liposome fusion and delivery vehicle |
| 08/12/1999 | WO1999039741A2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 08/12/1999 | WO1999039740A2 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 08/12/1999 | WO1999039735A1 Live vaccine for human immunodeficiency virus |
| 08/12/1999 | WO1999039734A1 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob |
| 08/12/1999 | WO1999039729A2 Use of heregulin as an epithelial cell growth factor |
| 08/12/1999 | WO1999039728A2 Methods of inducing hair growth and coloration |
| 08/12/1999 | WO1999039724A1 Treatment of bony defects with osteoblast precursor cells |
| 08/12/1999 | WO1999039582A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 08/12/1999 | WO1999039571A1 Nonhuman animal embryonic stem cells and nonhuman animals having variant smooth muscle myosin heavy-chain genes |
| 08/12/1999 | WO1999031260A3 Regulatory sequences involved in pancreas-specific gene expression |
| 08/12/1999 | WO1999031233A8 Polypeptides, polynucleotides and uses thereof |
| 08/12/1999 | WO1999031230A3 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 08/12/1999 | WO1999029884A3 Tgc method for inducting targeted somatic transgenesis |
| 08/12/1999 | WO1999029875A3 Plant uridine diphosphate-glucose dehydrogenase genes, proteins, and uses thereof |
| 08/12/1999 | WO1999028488A3 Pseudo-type retroviral vectors with modifiable surface capsid proteins |
| 08/12/1999 | WO1999028460A3 Molecules interacting with apoptin |
| 08/12/1999 | WO1999028344A3 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment |
| 08/12/1999 | WO1999027123A3 Modified sv40 viral vectors |
| 08/12/1999 | WO1999027116A3 Dna molecules conferring dalapon-resistance to plants and plants transformed thereby |
| 08/12/1999 | WO1999027107A3 Gram-positive microorganism formate transporters |
| 08/12/1999 | WO1999027093A3 The nip3 family of proteins |
| 08/12/1999 | WO1999027088A3 Novel gene and protein expressed in neural and pancreatic tissues |
| 08/12/1999 | WO1999027085A3 Method of parallel screening for insertion mutants and a kit to perform this method |
| 08/12/1999 | WO1999027084A9 Novel pectate lyases |
| 08/12/1999 | WO1999026975A3 Method for obtaining biologically active dimers of recombinant human growth factors from the cysteine knot family, use of dimers thus obtained |
| 08/12/1999 | WO1999025378A9 Immunoglobulin molecules having a synthetic variable region and modified specificity |
| 08/12/1999 | WO1999024607A9 DETECTION AND TYPING OF THE iceA GENE OF $i(HELICOBACTER PYLORI) |
| 08/12/1999 | WO1999024471A9 Opiate, cannabinoid, and estrogen receptors |
| 08/12/1999 | WO1999024050A9 High throughput method for functionally classifying proteins identified using a genomics approach |
| 08/12/1999 | WO1999022761A9 Conjugate heat shock protein-binding peptides |
| 08/12/1999 | WO1999021875A9 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 08/12/1999 | WO1999021574A9 Enhancement of morphogen activity |
| 08/12/1999 | WO1999018226A9 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 08/12/1999 | WO1999018195A3 Methods and compositions for inducing tumor-specific cytotoxicity |
| 08/12/1999 | WO1999015684A8 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 08/12/1999 | WO1999009177A3 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus |
| 08/12/1999 | WO1999004820A3 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 08/12/1999 | WO1998057662A3 Therapeutic systems |
| 08/12/1999 | DE19838967A1 Suppressing proliferation, tumor formation and metastasis of CD30-positive cells by contact with specific binding agent, for treating tumors |
| 08/12/1999 | DE19805431A1 Heteroaromatische Oligoamide als Affinitätsliganden Heteroaromatic oligoamides as affinity ligands |
| 08/12/1999 | DE19805351A1 New human G-protein coupled receptor from brain tissue, used to treat nervous system disorders, e.g. Alzheimer's disease, eating disorders and as cerebral protectant |
| 08/12/1999 | DE19805334A1 Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes A method of developing a pharmaceutical active ingredient |
| 08/12/1999 | DE19804210A1 Rekombinante Mistellektine Recombinant mistletoe |
| 08/12/1999 | CA2751655A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |